<DOC>
	<DOCNO>NCT00947219</DOCNO>
	<brief_summary>The purpose study evaluate change terminal hair count 16 26 week compare baseline measurement .</brief_summary>
	<brief_title>Treatment Androgenic Alopecia Males</brief_title>
	<detailed_description>This randomize , double-blind , control device clinical study across 3 site , evaluate change terminal hair-count evaluation zone evidence androgenetic alopecia ( miniaturize hair ) . The trial involve approximately 75 male subject diagnose androgenetic alopecia , 25 60 year age , Fitzpatrick Skin Types I-IV , classification Norwood-Hamilton IIa V , active hair loss within last 12 month . Subjects use device three non-consecutive day week direct per device 26 week treatment duration . Safety analysis assess base report adverse event study .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Diagnosis androgenetic alopecia Fitzpatrick Skin Types IIV NorwoodHamilton IIa V Active hair loss within last 12 month Photosensitivity laser light Malignancy target area</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Androgenetic Alopecia</keyword>
	<keyword>Hair Loss</keyword>
	<keyword>Male Pattern Baldness</keyword>
</DOC>